临床肿瘤学杂志

• 论著 •    下一篇

miR-203下调Bmi-1基因对肺腺癌细胞侵袭转移的影响


徐磊,蒋峰,杨欣,笪良山,钱亦淳,王洁,尹荣,许林
  

  1. 南京医科大学附属江苏省肿瘤医院胸外科 江苏省恶性肿瘤分子生物学及转化医学重点实验室
  • 收稿日期:2013-11-26 修回日期:2014-02-21 出版日期:2014-04-30 发布日期:2014-04-30
  • 通讯作者: 许林

The effect of miR-203 on the migration and invasion of lung adenocarcinoma cells via targeting Bmi-1

XU Lei, JIANG Feng, YANG Xin, DA Liangshan, QIAN Yichun, WANG Jie, YIN Rong, XU Lin   

  1. Department of Thoracic Surgery, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University,Jiangsu Key Laboratory of Molecular and Translational Cancer Research
  • Received:2013-11-26 Revised:2014-02-21 Online:2014-04-30 Published:2014-04-30
  • Contact: XU Lin

摘要: 目的 探讨miR-203在肺腺癌中的表达,并分析其与肺腺癌细胞侵袭转移的关系及其分子机制。方法 实时定量PCR检测40例肺腺癌患者肿瘤组织中miR-203的相对表达水平及其与临床病理特征之间的关系;实时定量PCR检测H1650、A549、H1975、SPC-A-1肺腺癌细胞株中miR-203表达水平;生物信息学软件预测miR-203潜在的靶基因;脂质体2000介导miR-203模拟物、Bmi-1基因或Bmi-1 siRNA转染H1975细胞株;Western blotting检测Bmi-1蛋白水平;双荧光素酶报告基因验证miR-203是否作用于Bmi-1 mRNA的3’UTR 区预测靶位;Transwell小室侵袭实验检测H1975细胞株的侵袭转移能力。
结果 40例肺腺癌组织中miR-203的相对表达量为0.065±0.013;肺腺癌miR-203表达与淋巴结转移有关,而与其他临床病理参数均无关;miR-203在肺腺癌细胞株H1650、A549、H1975、SPC-A-1中的相对表达量分别为0.280±0.102、0.308±0.168、0.167±0.073和0.287±0.096。生物信息学软件预测Bmi-1是miR-203的潜在靶基因;过表达miR-203可明显降低Bmi-1蛋白表达水平;双荧光素酶报告基因检测证明miR-203可作用于Bmi-1基因mRNA的 3’UTR区预测靶位。过表达miR-203+Bmi-1 siRNA可显著抑制肺腺癌细胞株H1975的侵袭迁移能力;在miR-203过表达的H1975细胞株中同时过表达Bmi-1可恢复其侵袭能力。
结论 miR-203可通过下调Bmi-1基因表达抑制H1975肺腺癌细胞株的侵袭转移,是一种潜在抑制转移的miRNA分子。

Abstract: Objective To investigate the expression of miR203 in lung adenocarcinoma and analyze the relationship between miR-203 and migration and invasion of lung adenocarcinoma cells. The involved molecular mechanisms are also initially explored. Methods miR-203 was detected in lung tissues of 40 patients with lung adenocarcinoma by real time PCR. The expression of miR-203 was detected in lung adenocarcinoma cell lines H1650, A549, H1975, SPC-A-1 by real time PCR. The potential target gene of miR203 was predicted by online bioinformatic softwares. Pre-miR-203 mimics, Bmi-1 gene and Bmi-1 siRNA were transfected into H1975 cell line by lipofectamine 2000. The Bmi-1 protein level was analyzed by Western blotting. The predicted miR-203 binding site in Bmi-1 3’untranslated region(UTR) was validated by dualluciferase reporter gene assay. The migration ability of H1975 cells was determined by Transwell assay.
Results The relative expression of miR-203 in lung adenocarcinoma tissues was 0.065±0.013. The expression level of miR-203 in the lymph node metastasis group was lower than those in the non-metastasis group. The relative expression of miR-203 in H1650, A549,H1975 and SPC-A-1 cell lines were 0.280±0.102,0.308±0.168,0.167±0.073 and 0.287±0.096, respectively. Bmi-1 was a potential target gene of miR-203 predicted by miRanda and TargetScan. The Bmi-1 protein level was remarkably decreased in the pre-miR-203 mimics group. Dual-luciferase reporter gene assay validated the predicted miR-203 binding site of Bmi-1 3’UTR. Overexpression of miR-203 significantly inhibited the migration and invasion of H1975 cells, whereas the cell migration and invasion ability could be restored by overexpression of Bmi-1. Conclusion miR-203 can suppress the migration of lung adenocarcinoma cell line H1975 via downregulating Bmi-1 expression. miR-203 might be a potential tumor metastasis suppressor miRNA.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!